ESCHERICHIA BACTERAEMIA side effect
What is ESCHERICHIA BACTERAEMIA ?ESCHERICHIA BACTERAEMIA : Cytarabine Side Effects Report #5615546-8
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Feb 04, 2008. Male patient, weighting 168.2 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: escherichia bacteraemia, sepsis, . CYTARABINE dosage: 36000 MG. Patient was hospitalized. Patient recovered.
ESCHERICHIA BACTERAEMIA : Prograf Side Effects Report #5478801-0
PROGRAF problem was reported by a Physician from UNITED STATES on Sept 17, 2007. Female patient, 16 years of age, weighting 141.1 lb, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: escherichia bacteraemia, escherichia urinary tract infection, . PROGRAF dosage: 2.5 MG, BID. During the same period patient was treated with ZENAPAX, ZANTAC, ARANESP, CLEOCIN. Patient was hospitalized. Patient recovered.
ESCHERICHIA BACTERAEMIA : Cytarabine Side Effects Report #5452125-X
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Sept 12, 2007. Male patient, weighting 182.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: escherichia bacteraemia, hypotension, neutropenia, respiratory failure, sepsis, . CYTARABINE dosage: 34740 MG. Patient was hospitalized. Patient recovered.
ESCHERICHIA BACTERAEMIA : Cytarabine Side Effects Report #5469440-6
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 25, 2007. Male patient, weighting 168.2 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: escherichia bacteraemia, sepsis, . CYTARABINE dosage: 36000 MG. Patient was hospitalized. Patient recovered.
ESCHERICHIA BACTERAEMIA : Prograf Side Effects Report #5405943-8
Physician from UNITED STATES reported PROGRAF problem on July 24, 2007. Female patient, 16 years of age, weighting 141.1 lb, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: escherichia bacteraemia, urinary tract infection, . PROGRAF dosage: unknown. During the same period patient was treated with ZENAPAX, ZANTAC, ARANESP, CLEOCIN. Patient was hospitalized. Patient recovered.
ESCHERICHIA BACTERAEMIA : Byetta Side Effects Report #5660765-8
BYETTA problem was reported by a Physician from UNITED STATES on Mar 03, 2008. Male patient was diagnosed with diabetes mellitus, rheumatoid arthritis and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: cholangitis, escherichia bacteraemia, gallbladder fistula, sepsis, . BYETTA dosage: unknown. During the same period patient was treated with ACTOS, METFORMIN, FOLIC ACID, MOBIC. Patient was hospitalized. Patient recovered.
ESCHERICHIA BACTERAEMIA : Cellcept Side Effects Report #5377485-X
Health Professional from UNITED STATES reported CELLCEPT problem on June 21, 2007. Male patient, 63 years of age, was diagnosed with prophylaxis against transplant rejection, antifungal prophylaxis and was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: diarrhoea, diverticulitis, escherichia bacteraemia, graft versus host disease, neutropenia, pancytopenia, pneumonitis, pulmonary haemorrhage, renal neoplasm, . CELLCEPT dosage: unknown. During the same period patient was treated with METHOTREXATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, FLUCONAZOLE. Patient was hospitalized. Patient died.
ESCHERICHIA BACTERAEMIA : Cellcept Side Effects Report #5377485-X
CELLCEPT problem was reported by a Health Professional from UNITED STATES on June 21, 2007. Male patient, 63 years of age, was diagnosed with prophylaxis against transplant rejection, antifungal prophylaxis and was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: diarrhoea, diverticulitis, escherichia bacteraemia, graft versus host disease, neutropenia, pancytopenia, pneumonitis, pulmonary haemorrhage, renal neoplasm, . CELLCEPT dosage: unknown. During the same period patient was treated with METHOTREXATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, FLUCONAZOLE. Patient was hospitalized. Patient died.